Lamotrigina Accord (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, reducing abnormal electrical activity and limiting the release of excitatory neurotransmitters such as glutamate. This stabilises neuronal membranes, decreasing seizure frequency and contributing to mood regulation.

The specific dose of Lamotrigina Accord is determined by the prescribing clinician based on the individual’s diagnosis, age, renal and hepatic function, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Lamotrigine is classified as Pregnancy Category C, meaning risk cannot be ruled out. It should only be used during pregnancy if the potential benefit justifies the potential risk. Limited data are available for breastfeeding; a healthcare professional should evaluate the risk‑benefit ratio.

To request Lamotrigina Accord, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older sodium channel blockers such as carbamazepine, lamotrigine generally has a more favourable side‑effect profile, especially regarding cognitive effects. However, it requires careful titration to minimise rash risk and has notable interactions with enzyme‑inducing agents, which differ from some alternatives.

Lamotrigina Accord should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer unless otherwise specified by the supplier.

Lamotrigina Accord is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication is typically started at a low dose and gradually increased to the target dose to reduce the risk of skin reactions.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behaviors. Patients should seek immediate medical attention if they notice any concerning symptoms.

Lamotrigina Accord is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic impairment, those taking interacting enzyme‑inducing drugs without proper dose adjustment, and pregnant women unless the benefits outweigh the risks.